Strong Association of a Common Dihydropyrimidine Dehydrogenase Gene Polymorphism with Fluoropyrimidine-Related Toxicity in Cancer Patients

BACKGROUND: Cancer patients carrying mutations in the dihydropyrimidine dehydrogenase gene (DPYD) have a high risk to experience severe drug-adverse effects following chemotherapy with fluoropyrimidine drugs such as 5-fluorouracil (5-FU) or capecitabine. The pretreatment detection of this impairment...

Descripción completa

Detalles Bibliográficos
Autores principales: Gross, Eva, Busse, Birgit, Riemenschneider, Matthias, Neubauer, Steffi, Seck, Katharina, Klein, Hanns-Georg, Kiechle, Marion, Lordick, Florian, Meindl, Alfons
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602733/
https://www.ncbi.nlm.nih.gov/pubmed/19104657
http://dx.doi.org/10.1371/journal.pone.0004003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602733/
https://www.ncbi.nlm.nih.gov/pubmed/19104657
http://dx.doi.org/10.1371/journal.pone.0004003

Ejemplares similares